Ceragenix, Megapharm Seal Distribution, Supply Agreement

Ceragenix Pharmaceuticals has signed an exclusive distribution and supply agreement with Megapharm, an Israeli company. The deal is to commercialize EpiCeram, a topical cream for treating atopic dermatitis and other dry skin conditions, in Israel and the Palestinian territories.

Reportedly, the agreement grants Megapharm exclusivity in the territory for the distribution and marketing of EpiCeram, while Ceragenix will be responsible for the manufacturing and supply of the product. Megapharm is also responsible for obtaining regulatory clearance to market EpiCeram in the region. Financial terms of the agreement were not yet disclosed.

Steven Porter, chairman and CEO of Ceragenix, said: “We are pleased to expand our international distribution network for EpiCeram by entering into this agreement with a well respected company such as Megapharm.”

Miron Drucker, CEO of Megapharm, commented: “We are delighted to have forged an agreement with Ceragenix to market EpiCeram Cream in Israel.”